Evidence map›Paper›PMID 32504743›Full record

ArticleThe Journal of infection2020

SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes.

N S N Graham, C Junghans, R Downes, C Sendall, H Lai, A McKirdy, P Elliott, R Howard, D Wingfield, M Priestman and 11 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 12 pooled it
60.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 12 syntheses or guidelines pooled it, 257 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Pooled it
  8. Pooled it
  9. Universal screening for SARS-CoV-2 infection: a rapid review.The Cochrane database of systematic reviews · 2020
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

N S N GrahamUK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK; Department of Brain Sciences, Imperial College London, UK.
C JunghansDepartment of Primary Care and Public Health, Imperial College London, UK.
R DownesDepartment of Elderly Medicine, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London W6 8RF, UK.
C SendallDepartment of Elderly Medicine, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London W6 8RF, UK.
H LaiUK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK; Department of Brain Sciences, Imperial College London, UK.
A McKirdyNorth West London Health Protection Team, Public Health England, 61 Colindale Avenue, Colindale, London NW9 5EQ, UK.
P ElliottUK DRI Centre at Imperial, Imperial College London, UK; MRC Centre for Environment and Health, Imperial College London, UK; BHF Centre of Excellence, Imperial College London, UK; Imperial NIHR Biomedical Research Centre, Imperial College London and Imperial College Healthcare NHS Trust, UK.
R HowardDivision of Psychiatry, UCL, 149 Tottenham Court Road, London W1T 7NF, UK.
D WingfieldDepartment of Metabolism, Digestion and Reproduction, Imperial College London, UK; Department of Primary Care and Public Health, Imperial College London, UK.
M PriestmanLondon Biofoundry, Imperial College Translation and Innovation Hub, White City Campus, 80 Wood Lane, London W12 0BZ, UK; Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, London SW7 2AZ, UK; UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK.
M CiechonskaLondon Biofoundry, Imperial College Translation and Innovation Hub, White City Campus, 80 Wood Lane, London W12 0BZ, UK; Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, London SW7 2AZ, UK; UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK.
L CameronSection of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, London SW7 2AZ, UK; UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK.
M StorchLondon Biofoundry, Imperial College Translation and Innovation Hub, White City Campus, 80 Wood Lane, London W12 0BZ, UK; Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, London SW7 2AZ, UK; UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK.
M A CroneLondon Biofoundry, Imperial College Translation and Innovation Hub, White City Campus, 80 Wood Lane, London W12 0BZ, UK; Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, London SW7 2AZ, UK; UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK.
P S FreemontLondon Biofoundry, Imperial College Translation and Innovation Hub, White City Campus, 80 Wood Lane, London W12 0BZ, UK; Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, London SW7 2AZ, UK; UK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK.
P RandellNorth West London Pathology, Charing Cross Hospital, London W6 8RF, UK; Imperial College Healthcare NHS Trust, Charing Cross Hospital, London W6 8RF, UK.
R McLarenPark Medical Centre, Hammersmith, London W6 0QG, UK.
N LangHammersmith and Fulham Council, 3 Shortlands, Hammersmith W6 8DA, UK.
S LadhaniImmunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
F SandersonDepartment of Infection, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London W6 8RF, UK. Electronic address: frances.sanderson@imperial.ac.uk.
D J SharpUK Dementia Research Institute Centre for Care Research and Technology, Imperial College London, UK; Department of Brain Sciences, Imperial College London, UK.
Imperial College London · GBLondon Biofoundry · GBUK Dementia Research Institute · GBCharing Cross Hospital · GBImperial College Healthcare NHS Trust · GBPublic Health England · GBUniversity College London · GBWestminster City Council · GB

Funding

Department of Health NIHR-RP-011-048
6 · The paper itself

Abstract

objectivesTo understand SARS-Co-V-2 infection and transmission in UK nursing homes in order to develop preventive strategies for protecting the frail elderly residents.

methodsAn outbreak investigation involving 394 residents and 70 staff, was carried out in 4 nursing homes affected by COVID-19 outbreaks in central London. Two point-prevalence surveys were performed one week apart where residents underwent SARS-CoV-2 testing and had relevant symptoms documented. Asymptomatic staff from three of the four homes were also offered SARS-CoV-2 testing.

resultsOverall, 26% (95% CI 22-31) of residents died over the two-month period. All-cause mortality increased by 203% (95% CI 70-336) compared with previous years. Systematic testing identified 40% (95% CI 35-46) of residents as positive for SARS-CoV-2, and of these 43% (95% CI 34-52) were asymptomatic and 18% (95% CI 11-24) had only atypical symptoms; 4% (95% CI -1 to 9) of asymptomatic staff also tested positive.

conclusionsThe SARS-CoV-2 outbreak in four UK nursing homes was associated with very high infection and mortality rates. Many residents developed either atypical or had no discernible symptoms. A number of asymptomatic staff members also tested positive, suggesting a role for regular screening of both residents and staff in mitigating future outbreaks.

Indexed as

BetacoronavirusNursing HomesAgedAged, 80 and overClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingFemaleHumansMalePandemicsPneumonia, ViralSARS-CoV-2Time FactorsUnited KingdomCare homeCoronavirusCOVID-19Diagnostic testingNursing homeSARS-CoV-2

Identifiers

PMID32504743
PMCPMC7836316
OpenAlexW3033725686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.